MeSH tree: C11.204
With Halloween just around the corner, thousands will be shopping for fancy dress contact lenses to go with their costume. The appeal is clear, as their endless colors and shapes allow you to radically change how you look—who ...
Oct 23, 2025
0
0
Many symptoms, such as hot flashes and vaginal dryness, are commonly associated with the menopause transition. One of the lesser-known symptoms that worsens in midlife is dry eyes. A new study suggests that postmenopausal ...
Oct 21, 2025
0
0
Researchers have successfully used artificial intelligence (AI) to predict which patients need treatment to stabilize their corneas and preserve their eyesight, in a study presented at the 43rd Congress of the European Society ...
Sep 13, 2025
0
1
Have you ever gone to the optometrist for an eye test and were told your eye was shaped like a football?
Jul 17, 2025
0
0
The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic solution) for the treatment of signs and symptoms of dry eye disease. Approval of Tryptyr was granted ...
Jun 3, 2025
0
1
It's as if she's squinting through a smoke-filled room. But it's Charisse Brown's eye condition, glaucoma, that diminishes her vision.
Jun 2, 2025
0
0
Researchers from the Faculty of Physics and the Life Sciences Center of Vilnius University (VU), with co-authors from Harvard University, the University of Toronto, National Cancer Institute and "Light Conversion," have developed ...
Mar 31, 2025
0
0
Rare eye diseases are the leading cause of untreatable blindness in Europe and affect people of all ages. The RESTORE VISION scientific team has identified seven rare ocular conditions that impact the cornea and the rest ...
Feb 28, 2025
0
0
Years ago, a young patient's mother told Emily McCourt, MD, associate professor of ophthalmology at the University of Colorado School of Medicine, that she hadn't used a prescribed ointment to treat her baby's chemical corneal ...
Feb 8, 2025
0
30
Researchers led by Osaka University in Japan have conducted the first human trial using induced pluripotent stem-cell-derived corneal epithelium to treat limbal stem cell deficiency, offering a potential new avenue for restoring ...
